Company page

Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. is a public company traded under the ticker PVLA in the American market. With a market capitalization of approximately $1.62 billion, the company focuses on developing innovative treatments for rare genetic diseases. Palvella is committed to advancing its pipeline to address unmet medical needs.